The public dataset TCIA (The Cancer Immunome Atlas, https://tcia.at/home) was then used to estimate the responsiveness of CTLA-4 and PD-1 immune checkpoint inhibitors based on the above results. This evidence concerns the gene CTLA4 and cancer.